The New England journal of medicine, 2022-03, Vol.386 (12), p.1143-1154
- Cortés, Javier
- Kim, Sung-Bae
- Chung, Wei-Pang
- Im, Seock-Ah
- Park, Yeon Hee
- Hegg, Roberto
- Kim, Min Hwan
- Tseng, Ling-Ming
- Petry, Vanessa
- Chung, Chi-Feng
- Iwata, Hiroji
- Hamilton, Erika
- Curigliano, Giuseppe
- Xu, Binghe
- Huang, Chiun-Sheng
- Kim, Jee Hyun
- Chiu, Joanne W.Y.
- Pedrini, Jose Luiz
- Lee, Caleb
- Liu, Yali
- Cathcart, Jillian
- Bako, Emarjola
- Verma, Sunil
- Hurvitz, Sara A.
2022
Details
- Autor(en) / Beteiligte
- Cortés, Javier
- Kim, Sung-Bae
- Chung, Wei-Pang
- Im, Seock-Ah
- Park, Yeon Hee
- Hegg, Roberto
- Kim, Min Hwan
- Tseng, Ling-Ming
- Petry, Vanessa
- Chung, Chi-Feng
- Iwata, Hiroji
- Hamilton, Erika
- Curigliano, Giuseppe
- Xu, Binghe
- Huang, Chiun-Sheng
- Kim, Jee Hyun
- Chiu, Joanne W.Y.
- Pedrini, Jose Luiz
- Lee, Caleb
- Liu, Yali
- Cathcart, Jillian
- Bako, Emarjola
- Verma, Sunil
- Hurvitz, Sara A.
- Titel
- Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
- Ist Teil von
- The New England journal of medicine, 2022-03, Vol.386 (12), p.1143-1154
- Ort / Verlag
- Massachusetts Medical Society
- Erscheinungsjahr
- 2022
- Link zum Volltext
- Quelle
- Electronic Journals Library
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMoa2115022Titel-ID: cdi_gale_healthsolutions_A708500666
- Format
- –